Unichem Laboratories gets USFDA approval for its Nebivolol Tablets
Unichem Laboratories Limited is pleased to announce that it has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA)
Mumbai: Unichem Laboratories Limitedis pleased to announce that it has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bystolic (nebivolol) Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg, of Allergan Sales, LLC. Nebivolol Tablets are indicated for the treatment of hypertension. The product will be commercialized from Unichem's Ghaziabad Plant.
Read Also - Unichem Labs gets USFDA nod for Divalproex Sodium ER Tablets
Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world. In India, The Company has strong skills in product development, process chemistry and manufacturing complex API as well as dosage forms.
Read Also - Unichem Labs gets USFDA nod for Amitriptyline HCl Tablets
Unichem Laboratories was founded in 1944 by Late Mr. Amrut Mody, a pioneer in the Indian pharmaceuticals business. With a rich tradition of unwavering quality and reliability, Unichem brings together a unique blend of modern, value-added research and deep knowledge of the Indian pharmaceuticals industry.
Read Also - Unichem Labs gets USFDA nod for Metformin Hydrochloride ER Tablets
